Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study (Q34294990)

1 August 2017

title

Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study (English)

1 reference

1 August 2017

5

Lisa A Bero

1 reference

1 August 2017

Erick H Turner

2

0 references

Brett D Thombs

object named as

Brett D Thombs

series ordinal

6

0 references

Joel Lexchin

series ordinal

3

object named as

Joel Lexchin

1 reference

1 August 2017

1

Michelle Roseman

1 reference

1 August 2017

James C Coyne

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

16 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

345

1 reference

1 August 2017

page(s)

e5155

1 reference

Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

The impact of disclosing financial ties in research and clinical care: a systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Factors associated with results and conclusions of trials of thiazolidinediones

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

The reporting quality of meta-analyses improves: a random sampling study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Pharmaceutical company funding and its consequences: a qualitative systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Epidemiology and reporting characteristics of systematic reviews

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Relative citation impact of various study designs in the health sciences

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Does declaration of competing interests affect readers' perceptions? A randomised trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Systems to rate the strength of scientific evidence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

A new system for grading recommendations in evidence based guidelines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

Toward More Uniform Conflict Disclosures

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423635

It's time to rebuild the evidence base

28 October 2018

1 reference

12 December 2020

The quality of drug studies published in symposium proceedings

1 reference

12 December 2020

CONSORT for reporting randomised trials in journal and conference abstracts

1 reference

12 December 2020

How pharmaceutical industry funding affects trial outcomes: causal structures and responses

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.E5155

1 reference

1 August 2017

1 reference

1 August 2017

1 reference